Abstract
Chronic soft tissue wound infections due to multidrug-resistant bacteria are a clinical challenge. Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus spp. (VRE), aminoglycoside-resistant Escherichia coli and Pseudomonas aeruginosa are examples of several problematic pathogens. A multipronged clinical approach is necessary for resolution of these chronic infections and a good medical outcome.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
